Cencora, Inc. (COR)
NYSE·Healthcare·Medical - Distribution
$312.84
+0.86%
Mkt Cap $62.84B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 4, 2026 | $86.06B | $85.93B | -0.15% | $4.05 | $4.08 | +0.74% | — | — |
| Q4 2025 Nov 5, 2025 | $83.46B | $83.73B | +0.32% | $3.79 | $3.84 | +1.32% | — | — |
| Q3 2025 Aug 6, 2025 | $80.09B | $80.66B | +0.71% | $3.85 | $4.00 | +3.90% | — | — |
| Q2 2025 May 7, 2025 | $75.68B | $75.45B | -0.30% | $4.11 | $4.42 | +7.54% | — | — |
| Q1 2025 Feb 5, 2025 | $78.31B | $81.49B | +4.06% | $3.50 | $3.73 | +6.57% | — | — |
| Q4 2024 Nov 6, 2024 | $77.62B | $79.05B | +1.84% | $3.23 | $3.34 | +3.41% | — | — |
| Q3 2024 Jul 31, 2024 | $73.32B | $74.24B | +1.26% | $3.22 | $3.34 | +3.73% | — | — |
| Q2 2024 May 1, 2024 | $70.60B | $68.41B | -3.09% | $3.69 | $3.80 | +2.98% | — | — |
| Q1 2024 Jan 31, 2024 | $69.17B | $72.25B | +4.45% | $2.89 | $3.28 | +13.49% | — | — |
| Q4 2023 Nov 2, 2023 | $66.02B | $68.92B | +4.39% | $2.81 | $2.86 | +1.78% | — | — |
| Q3 2023 Aug 2, 2023 | $63.95B | $66.95B | +4.69% | $2.82 | $2.92 | +3.55% | — | — |
| Q2 2023 May 2, 2023 | $60.40B | $63.46B | +5.05% | $3.30 | $3.50 | +6.06% | — | — |
| Q1 2023 Feb 1, 2023 | $62.81B | $62.85B | +0.06% | $2.64 | $2.71 | +2.65% | — | — |
| Q4 2022 Nov 3, 2022 | $60.54B | $61.17B | +1.05% | $2.57 | $2.60 | +1.17% | — | — |
| Q3 2022 Aug 3, 2022 | $59.08B | $60.06B | +1.67% | $2.56 | $2.62 | +2.34% | — | — |
| Q2 2022 May 4, 2022 | $57.48B | $57.72B | +0.41% | $2.93 | $3.22 | +9.90% | — | — |
| Q1 2022 Feb 2, 2022 | $59.60B | $59.63B | +0.05% | $2.58 | $2.58 | +0.00% | — | — |
| Q4 2021 Nov 4, 2021 | $57.64B | $58.91B | +2.20% | $2.36 | $2.39 | +1.27% | — | — |
| Q3 2021 Aug 4, 2021 | $52.35B | $53.41B | +2.02% | $2.01 | $2.16 | +7.46% | — | — |
| Q2 2021 May 5, 2021 | $49.92B | $49.15B | -1.53% | $2.51 | $2.53 | +0.80% | — | — |